A prospective study of 126 patients with T2DM with CKD stages 2–3 suggested that patients with a fracture event displayed higher levels of FGF23, and FGF23 could independently affect the occurrence of fracture (44). This evidence concerns the gene FGF23 and type 2 diabetes mellitus.